Immix Biopharma, Inc. (IMMX) News
Track canonical SquawkNews coverage tagged to IMMX, Immix Biopharma, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
IMMX Initiated Buy W/$21.00 PT at Needham
IMMX Initiated Buy W/$21.00 PT at Needham
EQUITY | Jul 22, 2026, 12:02 PM UTC
L
IMMX -14% - earlier pre-mkt 1-sentence 8-K filing from the company: "As of July 17, 2026, Richard Graydon has been terminated and is no long
IMMX -14% - earlier pre-mkt 1-sentence 8-K filing from the company: "As of July 17, 2026, Richard Graydon has been terminated and is no longer with the Company for reasons unrelated to his activities at the Company. Give
EQUITY | Jul 20, 2026, 02:41 PM UTC
L
IMMX -8% on day after CMO dismissed
IMMX -8% on day after CMO dismissed
EQUITY | Jul 20, 2026, 01:48 PM UTC
L
IMMX A most-wanted fugitive appears to have been secretly working as a Biotech executive Link To Story from STATNEWS.com
IMMX A most-wanted fugitive appears to have been secretly working as a Biotech executive Link To Story from STATNEWS.com
EQUITY | Jul 20, 2026, 01:46 PM UTC
M
IMMX: BofA Initiates Buy
B of A Securities initiates coverage on Immix Biopharma with a buy rating and a price target of $27
EQUITY | Jun 18, 2026, 10:55 AM UTC